Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
GADOFOSVESET
(2008)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
GADOFOSVESET
×
Maximum Phase:
4
First Approval:
2008
UNII:
E65RW73PHS
Molecule Type:
Small molecule
Molecular Formula:
C33H44GdN3O14P+3
Molecular Weight:
894.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TAPENTADOL HYDROCHLORIDE
(2008)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Acute Pain; Chronic Pain; Neuralgia; Pain
TAPENTADOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
71204KII53
Molecule Type:
Small molecule
Molecular Formula:
C14H24ClNO
Molecular Weight:
257.81
AlogP:
3.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FOSPROPOFOL
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSPROPOFOL
×
Maximum Phase:
4
First Approval:
2008
UNII:
LZ257RZP7K
Molecule Type:
Small molecule
Molecular Formula:
C13H21O5P
Molecular Weight:
288.28
AlogP:
3.38
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ELTROMBOPAG
(2008)
Small molecule
Unknown
ORAL
Approved
Hemorrhage
ELTROMBOPAG
×
Maximum Phase:
4
First Approval:
2008
UNII:
S56D65XJ9G
Molecule Type:
Small molecule
Molecular Formula:
C25H22N4O4
Molecular Weight:
442.48
AlogP:
4.56
PSA:
114.59
HBD:
3.0
HBA:
#RotB:
5.0
Source:
FOSAPREPITANT
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSAPREPITANT
×
Maximum Phase:
4
First Approval:
2008
UNII:
6L8OF9XRDC
Molecule Type:
Small molecule
Molecular Formula:
C23H22F7N4O6P
Molecular Weight:
614.41
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DESVENLAFAXINE
(2008)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder; Depressive Disorder, Major
DESVENLAFAXINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
NG99554ANW
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO2
Molecular Weight:
263.38
AlogP:
2.73
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RUFINAMIDE
(2008)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Lennox Gastaut Syndrome; Seizures
RUFINAMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
WFW942PR79
Molecule Type:
Small molecule
Molecular Formula:
C10H8F2N4O
Molecular Weight:
238.2
AlogP:
0.7
PSA:
73.8
HBD:
1.0
HBA:
#RotB:
3.0
Source:
METHYLNALTREXONE BROMIDE
(2008)
Small molecule
Mu opioid receptor antagonist
ORAL; SUBCUTANEOUS
Approved
Constipation
METHYLNALTREXONE BROMIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
RFO6IL3D3M
Molecule Type:
Small molecule
Molecular Formula:
C21H26BrNO4
Molecular Weight:
436.35
AlogP:
1.67
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BENDAMUSTINE HYDROCHLORIDE
(2008)
Small molecule
DNA inhibitor
INJECTION; IV (INFUSION)
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin
BENDAMUSTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2008
UNII:
981Y8SX18M
Molecule Type:
Small molecule
Molecular Formula:
C16H22Cl3N3O2
Molecular Weight:
394.73
AlogP:
3.26
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
9.0
Source:
LEVOLEUCOVORIN CALCIUM
(2008)
Small molecule
Unknown
INTRAVENOUS
Approved
Colorectal Neoplasms; Osteosarcoma
LEVOLEUCOVORIN CALCIUM
×
Maximum Phase:
4
First Approval:
2008
UNII:
778XL6VBS8
Molecule Type:
Small molecule
Molecular Formula:
C20H21CaN7O7
Molecular Weight:
511.51
AlogP:
-0.73
PSA:
219.84
HBD:
7.0
HBA:
#RotB:
10.0
Source:
FESOTERODINE FUMARATE
(2008)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
FESOTERODINE FUMARATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
EOS72165S7
Molecule Type:
Small molecule
Molecular Formula:
C30H41NO7
Molecular Weight:
527.66
AlogP:
5.38
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
10.0
Source:
TAPENTADOL
(2008)
Small molecule
Unknown
ORAL
Approved
Pain
TAPENTADOL
×
Maximum Phase:
4
First Approval:
2008
UNII:
H8A007M585
Molecule Type:
Small molecule
Molecular Formula:
C14H23NO
Molecular Weight:
221.34
AlogP:
3.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALVIMOPAN
(2008)
Small molecule
Mu opioid receptor antagonist
Unknown
Approved
Constipation
ALVIMOPAN
×
Maximum Phase:
4
First Approval:
2008
UNII:
Q153V49P3Z
Molecule Type:
Small molecule
Molecular Formula:
C25H32N2O4
Molecular Weight:
424.54
AlogP:
3.05
PSA:
89.87
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ARTEMETHER
(2009)
Small molecule
Ferriprotoporphyrin IX inhibitor
Unknown
Approved
Malaria
ARTEMETHER
×
Maximum Phase:
4
First Approval:
2009
UNII:
C7D6T3H22J
Molecule Type:
Small molecule
Molecular Formula:
C16H26O5
Molecular Weight:
298.38
AlogP:
2.84
PSA:
46.15
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ESLICARBAZEPINE ACETATE
(2009)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
ESLICARBAZEPINE ACETATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
BEA68ZVB2K
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O3
Molecular Weight:
296.33
AlogP:
3.06
PSA:
72.63
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TELAVANCIN
(2009)
Small molecule
Unknown
INJECTION
Approved
Bacterial Infections
TELAVANCIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
XK134822Z0
Molecule Type:
Small molecule
Molecular Formula:
C80H106Cl2N11O27P
Molecular Weight:
1755.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MILNACIPRAN
(2009)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
MILNACIPRAN
×
Maximum Phase:
4
First Approval:
2009
UNII:
G56VK1HF36
Molecule Type:
Small molecule
Molecular Formula:
C15H22N2O
Molecular Weight:
246.35
AlogP:
1.77
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SAXAGLIPTIN HYDROCHLORIDE
(2009)
Small molecule
Dipeptidyl peptidase IV inhibitor
ORAL
Approved
Diabetes Mellitus, Type 2
SAXAGLIPTIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
Z8J84YIX6L
Molecule Type:
Small molecule
Molecular Formula:
C18H26ClN3O2
Molecular Weight:
351.88
AlogP:
1.16
PSA:
90.35
HBD:
2.0
HBA:
#RotB:
2.0
Source:
OLANZAPINE PAMOATE
(2009)
Small molecule
D2-like dopamine receptor antagonist
INTRAMUSCULAR
Approved
Bipolar Disorder; Mental Disorders; Schizophrenia
OLANZAPINE PAMOATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
X7S6Q4MHCB
Molecule Type:
Small molecule
Molecular Formula:
C40H38N4O7S
Molecular Weight:
718.83
AlogP:
3.44
PSA:
30.87
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ASENAPINE
(2009)
Small molecule
Unknown
SUBLINGUAL; TRANSDERMAL
Approved
Bipolar Disorder; Psychotic Disorders; Schizophrenia
ASENAPINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
JKZ19V908O
Molecule Type:
Small molecule
Molecular Formula:
C17H16ClNO
Molecular Weight:
285.77
AlogP:
4.26
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ASENAPINE MALEATE
(2009)
Small molecule
Dopamine D2 receptor antagonist
SUBLINGUAL
Approved
Bipolar Disorder; Schizophrenia
ASENAPINE MALEATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
CU9463U2E2
Molecule Type:
Small molecule
Molecular Formula:
C21H20ClNO5
Molecular Weight:
401.85
AlogP:
4.26
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PAZOPANIB HYDROCHLORIDE
(2009)
Small molecule
Fibroblast growth factor receptor 1 inhibitor
ORAL
Approved
Carcinoma, Renal Cell; Sarcoma
PAZOPANIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
33Y9ANM545
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClN7O2S
Molecular Weight:
473.99
AlogP:
3.14
PSA:
119.03
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BEPOTASTINE BESYLATE
(2009)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Conjunctivitis, Allergic; Pruritus
BEPOTASTINE BESYLATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
6W18MO1QR3
Molecule Type:
Small molecule
Molecular Formula:
C27H31ClN2O6S
Molecular Weight:
547.07
AlogP:
4.17
PSA:
62.66
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CODEINE SULFATE
(2009)
Small molecule
Opioid receptors; mu/kappa/delta agonist
ORAL
Approved
Pain
CODEINE SULFATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
11QV9BS0CB
Molecule Type:
Small molecule
Molecular Formula:
C36H50N2O13S
Molecular Weight:
750.86
AlogP:
1.5
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DEXLANSOPRAZOLE
(2009)
Small molecule
Potassium-transporting ATPase inhibitor
ORAL
Approved
Duodenal Ulcer; Esophagitis; Gastroesophageal Reflux; Heartburn; Peptic Ulcer; Stomach Ulcer
DEXLANSOPRAZOLE
×
Maximum Phase:
4
First Approval:
2009
UNII:
UYE4T5I70X
Molecule Type:
Small molecule
Molecular Formula:
C16H14F3N3O2S
Molecular Weight:
369.37
AlogP:
3.52
PSA:
67.87
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CAPSAICIN
(2009)
Small molecule
Vanilloid receptor opener
TOPICAL
Approved
Arthralgia; Arthritis; Back Pain; Bursitis; Contusions; Muscle Cramp; Myalgia; Neuralgia; Osteoarthritis; Pain; Sprains and Strains; Tendinopathy
CAPSAICIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
S07O44R1ZM
Molecule Type:
Small molecule
Molecular Formula:
C18H27NO3
Molecular Weight:
305.42
AlogP:
3.79
PSA:
58.56
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ILOPERIDONE
(2009)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Psychotic Disorders; Schizophrenia
ILOPERIDONE
×
Maximum Phase:
4
First Approval:
2009
UNII:
VPO7KJ050N
Molecule Type:
Small molecule
Molecular Formula:
C24H27FN2O4
Molecular Weight:
426.49
AlogP:
4.83
PSA:
64.8
HBD:
0.0
HBA:
#RotB:
8.0
Source:
DRONEDARONE
(2009)
Small molecule
Unknown
ORAL
Approved
Arrhythmias, Cardiac
DRONEDARONE
×
Maximum Phase:
4
First Approval:
2009
UNII:
JQZ1L091Y2
Molecule Type:
Small molecule
Molecular Formula:
C31H44N2O5S
Molecular Weight:
556.77
AlogP:
7.05
PSA:
88.85
HBD:
1.0
HBA:
#RotB:
18.0
Source:
LUMEFANTRINE
(2009)
Small molecule
Ferriprotoporphyrin IX inhibitor
Unknown
Approved
Malaria
LUMEFANTRINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
ZUV4B00D9P
Molecule Type:
Small molecule
Molecular Formula:
C30H32Cl3NO
Molecular Weight:
528.95
AlogP:
9.15
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
10.0
Source:
DRONEDARONE HYDROCHLORIDE
(2009)
Small molecule
Inward rectifier potassium channel 2 blocker
ORAL
Approved
Atrial Fibrillation
DRONEDARONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
FA36DV299Q
Molecule Type:
Small molecule
Molecular Formula:
C31H45ClN2O5S
Molecular Weight:
593.23
AlogP:
7.05
PSA:
88.85
HBD:
1.0
HBA:
#RotB:
18.0
Source:
PRASUGREL HYDROCHLORIDE
(2009)
Small molecule
Purinergic receptor P2Y12 antagonist
ORAL
Approved
Acute Coronary Syndrome; Hemorrhage; Myocardial Infarction
PRASUGREL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
G89JQ59I13
Molecule Type:
Small molecule
Molecular Formula:
C20H21ClFNO3S
Molecular Weight:
409.91
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PAZOPANIB
(2009)
Small molecule
Unknown
Unknown
Approved
Neoplasms
PAZOPANIB
×
Maximum Phase:
4
First Approval:
2009
UNII:
7RN5DR86CK
Molecule Type:
Small molecule
Molecular Formula:
C21H23N7O2S
Molecular Weight:
437.53
AlogP:
3.14
PSA:
119.03
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BEPOTASTINE
(2009)
Small molecule
Unknown
Unknown
Approved
Unknown
BEPOTASTINE
×
Maximum Phase:
4
First Approval:
2009
UNII:
HYD2U48IAS
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
4.17
PSA:
62.66
HBD:
1.0
HBA:
#RotB:
8.0
Source:
VIGABATRIN
(2009)
Small molecule
Gamma-amino-N-butyrate transaminase inhibitor
ORAL
Approved
Epilepsy; Epilepsy, Complex Partial; Spasms, Infantile
VIGABATRIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
GR120KRT6K
Molecule Type:
Small molecule
Molecular Formula:
C6H11NO2
Molecular Weight:
129.16
AlogP:
0.36
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BESIFLOXACIN
(2009)
Small molecule
Unknown
Unknown
Approved
Eye Infections
BESIFLOXACIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
BFE2NBZ7NX
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClFN3O3
Molecular Weight:
393.85
AlogP:
3.14
PSA:
88.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SAXAGLIPTIN
(2009)
Small molecule
Unknown
ORAL
Approved
Diabetes Mellitus
SAXAGLIPTIN
×
Maximum Phase:
4
First Approval:
2009
UNII:
8I7IO46IVQ
Molecule Type:
Small molecule
Molecular Formula:
C18H25N3O2
Molecular Weight:
315.42
AlogP:
1.16
PSA:
90.35
HBD:
2.0
HBA:
#RotB:
2.0
Source:
1
2
…
58
59
60
61
62
63
64
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA